Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma
Michela Giuliano1, Ornella Pellerito, Patrizia Portanova
1Dipartimento di Scienze Biochimiche, Università di Palermo, Via del Vespro 129, 90127 Palermo, Italy.
Abstract:
It has recently been shown that cannabinoids induce growth inhibition and apoptosis in different tumour cell lines. In the current study, the effects of WIN 55,212-2 (WIN), a synthetic and potent cannabinoid receptor agonist, are investigated in hepatoma HepG2 cells and a possible signal transduction pathway is proposed. In these cells, WIN induces a clear apoptotic effect which was accompanied by up-regulation of the death-signalling factors Bax, Bcl-X(S), t-Bid and down-regulation of the survival factors survivin, phospho-AKT, Hsp72 and Bcl-2. Moreover, WIN-induced apoptosis is associated with JNK/p38 MAPK pathway activation and mitochondrial depolarisation demonstrated by a cytofluorimetric assay. The results also show that in HepG2 cells WIN markedly increases the level of the transcription factor PPARgamma in a dose- and time-dependent manner. The addition of the PPARgamma antagonists GW9662 and T0070907 significantly reduces the effects of the drug on both cell viability and the levels of survivin, phospho-AKT and phospho-BAD, suggesting that PPARgamma plays a key role in WIN-induced apoptosis. Altogether, the results seem to indicate a potential therapeutic role of WIN in hepatic cancer treatment.
Insights
Cannabinoids like WIN 55,212-2 induce apoptosis in liver cancer cells by activating specific pathways. This research suggests a potential therapeutic role for cannabinoids in treating hepatic cancer.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Cannabinoids are known to inhibit tumor cell growth and induce apoptosis.
- Understanding the specific mechanisms and pathways involved is crucial for therapeutic development.
Purpose of the Study:
- To investigate the effects of WIN 55,212-2, a cannabinoid receptor agonist, on hepatoma HepG2 cells.
- To elucidate the signal transduction pathway mediating WIN 55,212-2-induced apoptosis.
Main Methods:
- Treatment of HepG2 cells with WIN 55,212-2.
- Analysis of apoptosis-related gene and protein expression (Bax, Bcl-X(S), t-Bid, survivin, Bcl-2).
- Assessment of JNK/p38 MAPK pathway activation, mitochondrial membrane potential, and PPARgamma levels.
- Use of PPARgamma antagonists (GW9662, T0070907) to evaluate pathway involvement.
Main Results:
- WIN 55,212-2 induced apoptosis in HepG2 cells, altering expression of pro-apoptotic and anti-apoptotic factors.
- Apoptosis was linked to JNK/p38 MAPK activation and mitochondrial depolarization.
- WIN 55,212-2 increased PPARgamma levels in a dose- and time-dependent manner.
- PPARgamma antagonists significantly inhibited WIN 55,212-2's effects on cell viability and key signaling molecules.
Conclusions:
- WIN 55,212-2 triggers apoptosis in hepatoma cells through the activation of the JNK/p38 MAPK pathway.
- PPARgamma plays a critical role in mediating WIN 55,212-2-induced apoptosis in HepG2 cells.
- These findings suggest a potential therapeutic application of WIN 55,212-2 in hepatic cancer treatment.
More Related Videos
08:51Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
